CID 13260331

Piperazine, 1-(1-oxo-3-phenyl-2-propenyl)-4-(2-oxo-2-(1-pyrrolidinyl)ethyl)-, monohydrochloride, (e)-

Structural Information

Molecular Formula
C19H25N3O2
SMILES
C1CCN(C1)C(=O)CN2CCN(CC2)C(=O)/C=C/C3=CC=CC=C3
InChI
InChI=1S/C19H25N3O2/c23-18(9-8-17-6-2-1-3-7-17)22-14-12-20(13-15-22)16-19(24)21-10-4-5-11-21/h1-3,6-9H,4-5,10-16H2/b9-8+
InChIKey
CDXOFRCOANQFHU-CMDGGOBGSA-N
Compound name
(E)-1-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]-3-phenylprop-2-en-1-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

2
Patents

327.19467 Da
Monoisotopic Mass

1.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 328.20195 181.9
[M+Na]+ 350.18389 191.2
[M+NH4]+ 345.22849 187.5
[M+K]+ 366.15783 186.7
[M-H]- 326.18739 184.0
[M+Na-2H]- 348.16934 186.6
[M]+ 327.19412 183.3
[M]- 327.19522 183.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe